20 results on '"Adalimumab -- Research -- Product development"'
Search Results
2. AbbVie announces positive data from phase 2a study of ABBV-3373 to treat rheumatoid arthritis
3. New Findings from Genentech Inc. in the Area of Clinical Trials and Studies Reported (Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis ...)
4. AbbVie's phase 3 SELECT-PsA 1 study of Rinvoq to treat psoriatic arthritis meets primary and key secondary endpoints
5. Studies from University of Occupational and Environmental Health Update Current Data on Rheumatoid Arthritis (Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in ...)
6. Takeda Pharmaceutical announces results from Phase 3b head-to-head VARSITY study
7. Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Dual Glucagon-like Peptide-1 and Glucagon Receptor Agonist in Chinese Patients with Type 2 Diabetes at the International Diabetes Federation Congress 2021
8. Significant Weight Loss and Multiple Metabolic Benefits: Phase 1b Study Results of IBI362 in Chinese Participants with Overweight or Obesity Published in EClinicalMedicine by the Lancet
9. Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
10. Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Glucagon-like Peptide-1 and Glucagon Receptor Dual Agonist in Overweight or Obese Chinese Participants at the American Diabetes Association's 81st Scientific Sessions
11. United States : New First-in-Class Phase 3 Data Demonstrate TREMFYA (guselkumab) Maintained Skin Clearance Rates Through Nearly 5 Years of Continuous Use in Adult Patients with Moderate to Severe Plaque Psoriasis
12. Uni of Oxford studies adalimumab in Covid-19 patients in care homes Pfizer|BioNTech start enrolling Phase III Covid-19 vaccine study in South Africa
13. Innovent and Lilly Jointly Release Phase 3 Results of TYVYT (Sintilimab Injection) in Combination with GEMZAR (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
14. RINVOQ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis
15. Findings from University of Toronto Broaden Understanding of Psoriatic Arthritis [Ixekizumab Treatment of Biologic-naive Patients With Active Psoriatic Arthritis: 3-year Results From a Phase Iii Clinical Trial (Spirit-p1)]
16. Data from Medical University Advance Knowledge in Rheumatoid Arthritis (Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, ...)
17. Findings from Fudan University in Monoclonal Antibodies Provides New Insights (A Randomized, Double-Blind, Parallel-Group, Phase 1 Clinical Trial Comparing the Pharmacokinetic, Safety, and Immunogenicity of the Biosimilar HS016 and the ...)
18. Studies from University of Leeds Provide New Data on Rheumatoid Arthritis (Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study)
19. New Hidradenitis Suppurativa Study Results from Erasmus University Medical Center Described (Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials)
20. Findings on Psoriasis Reported by Investigators at St. Louis University (Comprehensive long-term safety of adalimumab from 18 clinical trials in adult patients with moderate-to-severe plaque psoriasis)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.